DIRS.INFO The most relevant business & tech news

And yet, the brain does incredible things," said Matt Angle, CEO and founder of Paradromics, in an interview with CNBC Tech: The Edge. The trial would follow competitor Neuralink, which implanted a chip into a patient's brain in March this year. "Paradromics' mission is to transform otherwise untreatable health conditions in brain health into solvable technology problems. "Paradromics can take the science and apply the right engineering to get us from research to medical device," he added. "We see that the first million people to get brain computer interfaces are going to be getting them to treat severe medical conditions," Angle said.

Persons: Matt Angle, Elon Musk, Angle, Vikash Gilja, Gilja, we're Organizations: CNBC Tech, CNBC Locations: Austin , Texas

☆ Inside Paradromics, the Neuralink competitor hoping to commercialize brain implants before the end of the decade
▼ + stars: | 2024-06-20 | by ( Maria Gomez De Sicart | ) www.cnbc.com time to read: +4 min

We're fundamentally building a medical device to serve unmet needs. What that does is it allows us to connect to the brain and receive data from the brain. And so Paradromics can take the science and apply the right engineering to get us from research to medical device. I work on developing processes or selecting the materials that we would like to use to build our cortical module, which is the brain implant portion of our system. We see that the first million people to get brain computer interfaces are going to be getting them to treat severe medical conditions.

Persons: Matt Angle, Paradromics, They're, I'm, Kimiko Nakajima, we're Organizations: BCI

Search resuls for: "Vikash Gilja"

2 mentions found